BICTF
Price:
$0.01
Market Cap:
$525.40K
Biocure Technology Inc., together with its subsidiary, engages in developing and commercializing biopharmaceutical technologies for use in recombinant and ranibizumab. The company is developing Interferons-ß for the treatment of multiple sclerosis; Ranibizumab, a monoclonal antibody fragment for the treatment of macular degeneration, as well as to treat a type of eye problem known as macular edema; and Filgrastim to treat neutropenia, a lack of white blood cells caused by cancer, bone marrow transplant, chemotherapy, or by other conditions. It also engages in the research and development of CAR T Cell therapy that identifies and destroys cancer cells; a foot and mouth disease vaccine; and ha...[Read more]
Industry
Biotechnology
IPO Date
2018-11-28
Stock Exchange
OTC
Ticker
BICTF
According to Biocure Technology Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.50. This represents a change of -99.90% compared to the average of -499.06 of the last 4 quarters.
The mean historical PE Ratio of Biocure Technology Inc. over the last ten years is -16500.69. The current -0.50 PE Ratio has changed -99.70% with respect to the historical average. Over the past ten years (40 quarters), BICTF's PE Ratio was at its highest in in the December 2021 quarter at 9.72. The PE Ratio was at its lowest in in the March 2017 quarter at -299700.00.
Average
-16500.69
Median
-67.65
Minimum
-164435.33
Maximum
-13.50
Discovering the peaks and valleys of Biocure Technology Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 7.44%
Maximum Annual PE Ratio = -13.50
Minimum Annual Increase = -99.94%
Minimum Annual PE Ratio = -164435.33
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -36.05 | -31.70% |
| 2023 | -52.78 | 291.09% |
| 2022 | -13.50 | -87.35% |
| 2021 | -106.66 | 70.73% |
| 2020 | -62.47 | 43.55% |
| 2019 | -43.52 | -40.25% |
| 2018 | -72.84 | -6.41% |
| 2017 | -77.83 | -26.50% |
| 2016 | -105.90 | -99.94% |
| 2015 | -164435.33 | 7.44% |
The current PE Ratio of Biocure Technology Inc. (BICTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-34.11
5-year avg
-54.29
10-year avg
-16500.69
Biocure Technology Inc.’s PE Ratio is greater than Biomind Labs Inc. (-26.90), less than Chia Tai Enterprises International Limited (9.22), greater than International Stem Cell Corporation (-18.99), less than Marizyme, Inc. (-0.01), less than Evofem Biosciences, Inc. (-0.21), less than Vaccinex, Inc. (-0.07), greater than Enzolytics Inc. (-3.29), less than Biora Therapeutics, Inc. (-0.07), less than Unity Biotechnology, Inc. (0), less than Medigene AG (-0.10),
| Company | PE Ratio | Market cap |
|---|---|---|
| -26.90 | $1.23M | |
| 9.22 | $217.44M | |
| -18.99 | $1.12M | |
| -0.01 | $39.54K | |
| -0.21 | $1.21M | |
| -0.07 | $1.34M | |
| -3.29 | $1.18M | |
| -0.07 | $994.99K | |
| 0 | $965.60K | |
| -0.10 | $38.15M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biocure Technology Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biocure Technology Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Biocure Technology Inc.'s PE Ratio?
How is the PE Ratio calculated for Biocure Technology Inc. (BICTF)?
What is the highest PE Ratio for Biocure Technology Inc. (BICTF)?
What is the 3-year average PE Ratio for Biocure Technology Inc. (BICTF)?
What is the 5-year average PE Ratio for Biocure Technology Inc. (BICTF)?
How does the current PE Ratio for Biocure Technology Inc. (BICTF) compare to its historical average?